Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TY6U
|
|||
| Drug Name |
BPX-601
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Gastric adenocarcinoma [ICD-11: 2B72] | Phase 1/2 | [1] | |
| Pancreatic cancer [ICD-11: 2C10] | Phase 1/2 | [1] | ||
| Prostate cancer [ICD-11: 2C82.0] | Phase 1/2 | [1] | ||
| Company |
Bellicum Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Prostate stem cell antigen (PSCA) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02744287) Use of Ligand-Inducible Autologous T Cells Engineered to Target PSCA on Tumor Cells in Selected Advanced Solid Tumors | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.